Troubled KV Issues Near-Total Recall

Law360, New York (January 28, 2009, 12:00 AM EST) -- KV Pharmaceutical Co. has suspended all of its manufacturing and shipping processes and issued a sweeping recall that encompasses most of its products, a move that comes after weeks of concerns over potentially fatal side effects linked to the company's generic pain drug hydromorphone HCl, among other issues.

St. Louis-based KV said Monday it had voluntarily suspended the manufacturing and shipping of all of its products, other than certain products that it distributes but does not manufacture, beginning on Jan. 22.

The company also revealed that...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.